Orcimed Life Sciences Private Limited, a active private limited company, was established on 24 February 2022 in Hyderabad, Telangana, India. Engaging in biotechnology within the information and communication sector, it holds CIN: U85300TG2022PTC160068. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.15 M and a paid-up capital of ₹97.00 K .
Employing 212 professional, Its leadership includes Kranthi Kumar Chintala (Director), Agrella Jr Charles David (Director), Someshwar Komuravelli (Director). Past directors included Kranthi Kumar Chintala, Agrella Jr Charles David, Sumanchandra Maarisetty. It holds ₹5.00 Cr open charges and ₹5.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 2Nd & 3Rd Floor, Plot No.226, Jubliee Hills, Road No.1, Hyderabad, Telangana, 500033.
U85300TG2022PTC160068
160068
24 February 2022
₹0.15 M
₹97.00 K
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Orcimed Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kranthi Kumar Chintala | Director | 11 Jul 2022 | Current |
| Agrella Jr Charles David | Director | 01 Sep 2022 | Current |
| Someshwar Komuravelli | Director | 24 Feb 2022 | Current |
| Saleha Fatima Quadri | Director | 24 Feb 2022 | Current |
| Apurva Srigiri | Director | 24 Feb 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Dec 2023 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2023 | Past |
| Pramod Abcsdd | Ceo | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Orcimed Life Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Orcimed Life Sciences had a public holding of 37.24%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹50,000,000.00
₹50,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Mar 2023 | Canara Bank | ₹5.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Orcimed Life Sciences has a workforce of 212 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Orcimed Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orcimed Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 08 Mar 2023 via Charge ID 100729631 with Canara Bank was fully satisfied on 20 May 2025. was recorded as a recent event.
Progress on Orcimed Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Orcimed Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
A charge with Canara Bank amounted to Rs. 50.00 M with Charge ID 100729631 was registered on 08 Mar 2023. was recorded as a recent event.
The activity Agrella Jr Charles David was appointed as a Director was appointed as a Director on 01 Sep 2022 & has been associated with this company since 3 years 3 months . was completed.
Progress on Kranthi Kumar Chintala was appointed as a Director was appointed as a Director on 11 Jul 2022 & has been associated with this company since 3 years 4 months . was documented.
The CIN of Orcimed Life Sciences Private Limited is U85300TG2022PTC160068.
Orcimed Life Sciences Private Limited is headquartered at 2Nd & 3Rd Floor, Plot No.226, Jubliee Hills, Road No.1, Hyderabad, Telangana, 500033.
Orcimed Life Sciences Private Limited was incorporated on 24 February 2022.
The current directors of Orcimed Life Sciences Private Limited are
The primary industry of Orcimed Life Sciences Private Limited is Information And Communication.
Orcimed Life Sciences Private Limited is unlisted.
The authorized capital of Orcimed Life Sciences Private Limited is ₹0.15 M, and the paid-up capital is ₹97.00 K .
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX